Baxter International Inc.
BAX Real Time Price USDRecent trades of BAX by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in BAX holdings by institutional investors
Quarterly net insider trading by BAX's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$30,000 Jan 06, 2022 Issue: Medicare/Medicaid Health Issues
-
$30,000 Oct 13, 2021 Issue: Health Issues Medicare/Medicaid
-
$30,000 Jul 12, 2021 Issue: Health Issues Medicare/Medicaid
-
$30,000 Apr 08, 2021 Issue: Health Issues Medicare/Medicaid
-
$30,000 Jan 07, 2021 Issue: Medicare/Medicaid Health Issues
BAX Estimated quarterly lobbying spending
BAX Revenue by Segment or Geography
New BAX patent grants
-
Patent Title: Infusion pump rack Jun. 13, 2023
-
Patent Title: Syringe pump Jun. 13, 2023
-
Patent Title: Sensor patch Jun. 06, 2023
-
Patent Title: Infusion pump with rechargeable battery Sep. 27, 2022
-
Patent Title: Connector for sensor Sep. 13, 2022
-
Patent Title: Sensor May. 24, 2022
-
Patent Title: Monitor connector Jul. 06, 2021
-
Patent Title: Dual chamber flexible container Oct. 27, 2020
-
Patent Title: Portable electronic display with animated gui Sep. 29, 2020
-
Patent Title: Portable electronic display with animated gui Sep. 22, 2020
-
Patent Title: Portable electronic display with animated gui Sep. 22, 2020
-
Patent Title: Antimicrobial housing and cover for a medical device Jun. 25, 2019
-
Patent Title: Weight-controlled sorbent system for hemodialysis Nov. 14, 2017
-
Patent Title: Drip chamber with hydrophobic interior surface Oct. 31, 2017
-
Patent Title: Method of controlling medical fluid therapy machine brightness Oct. 24, 2017
-
Patent Title: Blood treatment air purging methods Oct. 24, 2017
-
Patent Title: Pumping systems for cassette-based dialysis Oct. 24, 2017
-
Patent Title: Optical imaging assembly and system with optical distortion correction Oct. 17, 2017
-
Patent Title: Solenoid pinch valve apparatus and method for medical fluid applications having reduced noise production Oct. 10, 2017
-
Patent Title: Peritoneal dialysis systems and methods having graphical user interface Oct. 03, 2017
-
Patent Title: Systems and methods for performing dialysis Sep. 19, 2017
-
Patent Title: Systems and methods for performing hemodialysis Sep. 12, 2017
-
Patent Title: System and method for peritoneal dialysis exchanges having reusable fill and drain containers Sep. 05, 2017
-
Patent Title: Hybrid blood and peritoneal dialysis treatment systems and methods Aug. 29, 2017
-
Patent Title: Automated dialysis system using piston and negative pressure Aug. 29, 2017
-
Patent Title: Dialysis system having non-invasive fluid velocity sensing Aug. 08, 2017
-
Patent Title: Injectable fibrin composition for bone augmentation Aug. 08, 2017
-
Patent Title: Surfactant systems for delivery of organic compounds Jul. 11, 2017
-
Patent Title: Dialysis system having approved therapy prescriptions presented for selection Jul. 04, 2017
-
Patent Title: Methods and apparatus for programming a medical pump Jun. 27, 2017
-
Patent Title: Dialysis treatment prescription system and method Jun. 27, 2017
-
Patent Title: Peritoneal dialysis connection system and method for using ultraviolet light emitting diodes Jun. 27, 2017
-
Patent Title: Infusion pump and method to enhance long term medication delivery accuracy Jun. 20, 2017
-
Patent Title: Dialysis systems including therapy prescription entries Jun. 13, 2017
-
Patent Title: Method of operating a disposable pumping unit Jun. 13, 2017
-
Patent Title: Monocyte activation test better able to detect non-endotoxin pyrogenic contaminants in medical products Jun. 06, 2017
-
Patent Title: Acoustic line tracing system and method for fluid transfer system May. 23, 2017
-
Patent Title: Immobilization of an active agent on a substrate using compounds including trihydroxyphenyl groups May. 23, 2017
-
Patent Title: Renal failure therapy machines and methods including convective and diffusive clearance May. 09, 2017
-
Patent Title: Immobilization of an active agent on a substrate May. 09, 2017
-
Patent Title: Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis Apr. 25, 2017
-
Patent Title: Optimization of nucleation and crystallization for lyophilization using gap freezing Apr. 18, 2017
-
Patent Title: Pressure manifold system for dialysis Apr. 18, 2017
-
Patent Title: Sealant applicator with malleable section Apr. 18, 2017
-
Patent Title: Devices, systems, and methods for cleaning, disinfecting, rinsing, and priming blood separation devices and associated fluid lines Apr. 11, 2017
-
Patent Title: Infusion system using optical imager for controlling flow and method thereof Mar. 28, 2017
-
Patent Title: Medical fluid machine with supply autoconnection Mar. 07, 2017
-
Patent Title: Method of performing peritoneal dialysis using pneumatic valves Mar. 07, 2017
-
Patent Title: Networked dialysis system Feb. 28, 2017
-
Patent Title: Needleless connector Jan. 24, 2012
Federal grants, loans, and purchases
Estimated quarterly amount awarded to BAX from public contracts
Recent insights relating to BAX
Recent picks made for BAX stock on CNBC
ETFs with the largest estimated holdings in BAX
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $BAX stock a Buy, Sell, or Hold?
- What is the price target for $BAX stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $BAX stock?
- Who owns the most shares of $BAX stock?
- What funds own $BAX stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view BAX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
- Address Deerfield, IL
- Market Cap 9.4 billion
- Employees 38,000
- Industrial Classification Surgical & Medical Instruments & Apparatus